login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BAUDAX BIO INC (BXRX) Stock News
USA
- NASDAQ:BXRX -
US07160F4046
-
Common Stock
0.1864
USD
+0 (+0.59%)
Last: 11/15/2023, 8:21:44 PM
0.17
USD
-0.02 (-8.8%)
After Hours:
11/15/2023, 8:21:44 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BXRX Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
GRI
COCP
OPGN
BBLG
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
2 years ago - By: Benzinga
- Mentions:
CERS
CLDX
OPRX
MLTX
...
12 Health Care Stocks Moving In Monday's Pre-Market Session
2 years ago - By: InvestorPlace
Why Is Baudax Bio (BXRX) Stock Up 75% Today?
2 years ago - By: Baudax Bio
Baudax Bio Acquires TeraImmune, Inc.
2 years ago - By: InvestorPlace
- Mentions:
APRN
OPGN
NVOS
RVLP
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
2 years ago - By: Seeking Alpha
Baudax Bio files to sell 15M shares of common stock for holders. (NASDAQ:BXRX)
2 years ago - By: Baudax Bio
Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
2 years ago - By: Baudax Bio
Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
2 years ago - By: Baudax Bio
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
2 years ago - By: InvestorPlace
- Mentions:
INVO
SIGA
UFAB
GBNH
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
2 years ago - By: Seeking Alpha
Baudax Bio shares more than double after TeraImmune acquisition (NASDAQ:BXRX)
Please enable JavaScript to continue using this application.